Evolocumab Versus LDL Apheresis in Patients With Hypercholesterolemia
Status:
Completed
Trial end date:
2018-01-28
Target enrollment:
Participant gender:
Summary
An open-label, prospective phase III study to compare the efficacy and safety of
administering evolocumab versus treatment with LDLapheresis in patients with familial
hypercholesterolemia and high cardiovascular risk.